Articles On Resonance Health (ASX:RHT)

Summary ASX-listed digital health company ResApp Health has recruited the first participant in its US-based trial to assess the link between cough and COVID-19. Botanix Pharmaceuticals revealed encouraging results from the BTX 1204A Pi...

Tech stocks lift Wall Street as iron ore tumbles 12% All major indices in US rose on Friday, with the Dow Jones climbing by 1.06%, the S&P 500 rising 1.49%, and tech-heavy NASDAQ rising by 2.32%. Tech stocks led the charge, as US Treasu...

Here’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks for small-cap health companies, with 58 companies gaining ground and 54 losing it. Another 16 were flat. Code Company Price % return...

Source: Shutterstock Summary ASX-listed medical imaging company Resonance Health has obtained CE marking to sell its device within the EEA. Resonance Health will provide HepaFat-AI to radiologists, physicians, and pharmaceutical compa...

The Resonance Health Ltd (ASX: RHT) share price rocketed more than 16% today before closing 5% higher. The booming share price moves come after the company emerged from a trading halt late this morning. This follows the release of an annou...

The Resonance Health Limited (ASX: RHT) share price has been placed in a trading halt. This comes after an announcement by the company this afternoon. Prior to the halt, the Resonance Health share price was trading narrowly higher. Rising...

Summary Medical device software of Resonance Health, HepaFat-AI added into Blackford Analysis partner agreement for distribution. Recently, HepaFat-AI had received regulatory clearance from the FDA. Resonance Health is looking forward...

The Resonance Health Limited (ASX: RHT) share price is soaring today after the company announced an agreement involving its flagship artificial intelligence (AI) device. The Resonance Health share price has surged up 9.3% to trade at 23.5...

Summary Medical imaging company Resonance Health Limited has received FDA clearance for its medical device, HepaFat-AI. The Company aims to actively take up various marketing routes for the automated medical device. The medical imagin...

The Resonance Health Limited (ASX: RHT) share price is shooting the lights out today. This comes after the company announced it has received a 510(k) clearance from the United States Food and Drug Administration (FDA) for its HepaFat-AI so...

Resonance Health (ASX:RHT) is the latest health stock to obtain FDA approval. The company’s HepaFat-AI software monitors liver health and ... Read More The post Resonance Health shares surge after its liver health monitoring software gets F...

In late morning trade the S&P/ASX 200 Index (ASX: XJO) is on course to record a solid gain. At the time of writing, the benchmark index is up 0.65% to 6,731.2 points. Four shares that are climbing more than most today are listed below....

Smartphone screen protector maker Nanoveu (ASX:NVU) is running hard this morning after receiving more proof that its antiviral screen cover can kill coronavirus — just not the one everyone is talking about. Montana lab Bioscience Laboratori...

From the bulging file of Nasty Obscure Diseases we present idiopathic intracranial hypertension (IIH), a condition characterised by debilitating chronic daily headaches and in some cases severe vision impairment. It’s a poorly treated condi...

Last year, in July, pharmaceuticals company Probiotec (ASX:PBP) announced and completed a $23m acquisition in 31 days. In its half-year report issued today the company said that purchase of contract pharmaceuticals maker ABS was largely beh...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

3DR Laboratories will now sell Resonance Health’s (RHT) FerriSmart MRI service in the United States FerriSmart uses artificial intelligence to determine the liver iron concentration from an MRI Monitoring of iron levels is important in p...

Resonance Health’s (ASX: RHT) “gold standard” FerriSmart magnetic resonance imaging service will be marketed and sold in the United Stated via an agreement with Accumen subsidiary 3DR Laboratories. FerriSmart uses artificial intelligence to...

Resonance Health (ASX:RHT) has licensed its flagship liver iron concentration MRI service to another distributor in its biggest market, the US. 3DR has bought a non-exclusive licence to sell FerriSmart in the US. The stock was up 24 per cen...

The Resonance Health Limited (ASX: RHT) share price has rocketed 20% this morning after the company announced it has entered into a license and royalty agreement with 3DR Laboratories. Under the agreement, 3DR Laboratories has the non-excl...

Here’s our monthly wrap of all the news driving ASX health stocks. Of the ASX’s 137-odd small cap health stocks, 92 saw their share prices fall, 32 improved and 13 were flat. >> Scroll down for a table showing the performance of small...

Resonance Health Limited (ASX: RHT) has entered into a Solution Partner Agreement with Siemens Healthcare GmbH to market its FerriSmart product via the digital marketplace of Siemens Healthcare. The agreement is for an initial period of th...

Artificial intelligence (AI) is about to be big business, according to the CSIRO’s innovation hub Data61. The research centre estimates that digital tech (including AI) will contribute an extra $315 billion in gross economic value to Austra...

Medical devices are one of an essential parts of health care system. These are used for accurate diagnosis of the disease and help health care professional to treat patients and improve their life quality. Medical device market in Australia...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms. The market opens at 10am (easte...

Here’s our fortnightly wrap of all the news driving ASX small cap health stocks. We last checked in with ASX small cap health stocks just hours after Opthea’s (ASX:OPT) anti macular degeneration drug passed a large clinical test with flying...

On Stockhead today – brewers saving our beer from climate change, why BHP will never get St George’s ‘freakish’ nickel belt, and an expert’s hot tech stock tips. But first here’s what you need to know.   The day ahead All eyes tomorrow are...

Healthcare being a large industry in Australia is a significant contributor to the country’s economy. The below-mentioned ASX listed healthcare stocks have been performing well over the past few months, plus have made strong operational pro...